Senior insider sale
SVP, Finance & Accounting at KURA ONCOLOGY, INC. — senior position signals high conviction
$49.6K
4.61K shares
What this filing means
DOYLE THOMAS JAMES plans to sell 4.61K shares of KURA ONCOLOGY, INC. valued at approximately $49.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/29/2026ACC: 0001193125-26-405710
Officer· SVP, Finance & Accounting
Since Feb 2022
4.61K
Shares to sell
$49.6K
Approx. market value
4.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
PSU
N/A
9/27/2026
4.61KTotal acquired4.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/27/2026 | PSU N/A | 4.61K | — |
| Total | 4.61K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.61K
Market value
$49.6K
9/28/2026
Total
Units
4.61K
Value
$49.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/28/2026 | 4.61K | $49.6K | NASDAQ | Planned |
| Total | 4.61K | $49.6K | ||